Will a general-purpose biological materials manufacturing platform be publicly demonstrated before 2035?

Prediction market on metaculus. Biological manufacturing has traditionally been organized around product-specific platforms. In recent years, researchers and funding agencies have shown [growing interest](https://www.bakerlab.org/2024/03/19/simplifying-nanoscale-design-with-regular-protein-building-blocks/) in [more flexible biological production systems](https://www.darpa.mil/research/programs/living-foundries), supported by better automation and modular biomolecular design tools. Advances in AI-driven molecular design, especially [AlphaFold](https://deepmind.google/science/alphafold/) and later systems, have made it easier to [model proteins](https://www.quantamagazine.org/how-ai-revolutionized-protein-science-but-didnt-end-it-20240626/) and other biomolecular interactions relevant to design work. Even so, fully general biological manufacturing platforms remain a research goal rather than an established capability.

Resolves: 1/1/2036.